DOSING VAGAL NERVE STIMULATION THERAPY IN SYNCHRONIZATION WITH TRANSIENT EFFECTS
First Claim
Patent Images
1. A method of using an implantable medical device comprising:
- delivering electrical stimulation proximate nerve tissue of a patient during a transient physiological effect period separated by a recovery period, the transient physiological effect period is when electrical stimulation has an increased level of efficacy and the recovery period is when additional electrical stimulation does not provide a beneficial physiological effect to the patient.
1 Assignment
0 Petitions
Accused Products
Abstract
The present disclosure is directed to a method of using an implantable medical device. One embodiment of the present disclosure comprises delivering electrical stimulation proximate nerve tissue of a patient during a transient physiological effect period separated by a recovery period. The transient physiological effect period is when electrical stimulation has an increased level of efficacy and the recovery period is when additional electrical stimulation does not provide a beneficial physiological effect to the patient.
-
Citations
21 Claims
-
1. A method of using an implantable medical device comprising:
delivering electrical stimulation proximate nerve tissue of a patient during a transient physiological effect period separated by a recovery period, the transient physiological effect period is when electrical stimulation has an increased level of efficacy and the recovery period is when additional electrical stimulation does not provide a beneficial physiological effect to the patient. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10)
-
11. A method of using an implantable medical device comprising:
-
delivering electrical stimulation proximate nerve tissue of a patient; determining a first physiological condition is higher than a target physiological condition; determining an end to a transient physiological effect period; ceasing electrical stimulation in response to determining the end of the transient physiological effect period; determining an end of a recovery period; determining a second physiological condition is higher than the target physiological condition; and delivering automatically electrical stimulation proximate the nerve tissue in response to determining a second physiological condition is greater than the target physiological condition. - View Dependent Claims (12, 13, 14, 15)
-
-
16. A method of using an implantable medical device comprising:
-
determining a baseline heart rate; determining a target heart rate; determining a first heart rate is equal to or greater than the target heart rate; initiating electrical stimulation proximate vagal nerve tissue of the patient, in response to determining the first heart rate is equal to or greater than the target heart rate; determining a second heart rate is equal to or greater than the target heart in response to initiating electrical stimulation proximate vagal nerve tissue; determining an end to a transient physiological effect period in response to determining the second heart rate; ceasing electrical stimulation in response to determining the end of the transient physiological effect period; determining an end of a recovery period in response to ceasing delivery of the electrical stimulation; determining a third heart rate is equal to or greater than the target heart rate in response to determining the end of the recovery period; and delivering automatically electrical stimulation proximate vagal nerve tissue of the patient, in response to determining a third heart rate is equal to or greater than the target heart rate. - View Dependent Claims (17, 18)
-
-
19. A method of using an implantable medical device comprising:
-
determining a first heart rate in a patient; delivering electrical stimulation proximate vagal nerve tissue of the patient until a predetermined second heart rate is attained during a transient effect period, the second heart rate is lower than the first heart rate; ceasing electrical stimulation in response to determining a second heart rate; determining the heart rate starting to return to or completely returning to the first heart rate after a diminishing effect period; delivering automatically electrical stimulation proximate vagal nerve tissue of the patient after a recovery period has ended; and lowering the heart rate to the second heart rate. - View Dependent Claims (20)
-
-
21. A method of obtaining a target heart rate through use of an implantable medical device comprising:
delivering electrical stimulation proximate vagal nerve tissue of a patient during a transient physiological effect period separated by a recovery period, the transient physiological effect period is when electrical stimulation has an increased level of efficacy and the recovery period is when additional electrical stimulation does not provide a beneficial physiological effect to the patient.
Specification